Select Page

Latest News from HNF

Stay up to date with our most recent news and updates on CMT and INs.

Pharnext Announces PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) Designation by UK Medicines and Healthcare Products Regulatory Agency

PARIS, France, 8:30 a.m., March 18, 2020 (CET) – Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on big genomics data and artificial intelligence, today announced that the...

Pharnext raises € 7.7 million in a private placement

PARIS, France, 08:30 a.m., March 05, 2020 (CET) – Pharnext SA (FR0011191287 - ALPHA) (the “Company”), a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on its PLEOTHERAPY artificial intelligence platform harnessing...

ACE-083 did not achieve statistically significant improvements in functional endpoints relative to placebo; Acceleron to discontinue development of ACE-083.

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that treatment...

The Hereditary Neuropathy Foundation’s Movement is Medicine™ Program Expands to Florida and Continues to Shed Light on the Impact Exercise Has on Charcot-Marie-Tooth (CMT)

  NEWS PROVIDED BY Hereditary Neuropathy Foundation  Mar 03, 2020, 06:03 ET NEW YORK, March 3, 2020 /PRNewswire/ -- The Hereditary Neuropathy Foundation (HNF) Movement is Medicine™ is expanding across the US with its latest Summit announced for March 21,...

HNF on the Forefront of Pain Research to Support CMT Patients

Allison Moore, HNF Founder/CEO, along with her team, took action and led the HNF groundbreaking CMT pain initiative to help the community.

Pharnext raises € 7.7 million in a private placement

Pharnext raises € 7.7 million in a private placement

PARIS, France, 08:30 a.m., March 05, 2020 (CET) – Pharnext SA (FR0011191287 - ALPHA) (the “Company”), a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on its PLEOTHERAPY artificial intelligence platform harnessing...

read more
Telling Our Story

Telling Our Story

Lots of people have seen Chris Wodke in her Team CMT uniform but fewer have seen her in her other uniform, as a member of the National Ski Patrol (NSP).

read more

Archives